Seropositivity to tumour antigens as a potential new biomarker for melanoma relapse | Dr Paul Nathan at ECC 2015

At the European Cancer Congress (ECC) 2015, Paul Nathan, MB.BS, BSc (Hons), BA, PhD, FRCP, of Mount Vernon Cancer Centre, Northwood, UK, discusses a study that was designed to determine whether seropo... Author: EMJ Added: 11/17/2015
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts